0001209191-21-067867.txt : 20211203
0001209191-21-067867.hdr.sgml : 20211203
20211203170254
ACCESSION NUMBER: 0001209191-21-067867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211203
DATE AS OF CHANGE: 20211203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brandenberger Ralph
CENTRAL INDEX KEY: 0001853197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 211470883
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 102
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-01
0
0001787400
Nkarta, Inc.
NKTX
0001853197
Brandenberger Ralph
6000 SHORELINE COURT
SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. VP, Technical Operations
Common Stock
2021-12-01
4
M
0
340
0.41
A
340
D
Common Stock
2021-12-01
4
M
0
405
4.77
A
745
D
Common Stock
2021-12-01
4
M
0
1358
3.89
A
2103
D
Common Stock
2021-12-01
4
M
0
2037
3.89
A
4140
D
Common Stock
2021-12-01
4
S
0
4140
15.64
D
0
D
Stock Option (right to buy)
0.41
2021-12-01
4
M
0
340
0.00
D
2028-07-18
Common Stock
340
7707
D
Stock Option (right to buy)
4.77
2021-12-01
4
M
0
405
0.00
D
2029-05-10
Common Stock
405
9190
D
Stock Option (right to buy)
3.89
2021-12-01
4
M
0
1358
0.00
D
2029-09-05
Common Stock
1358
30784
D
Stock Option (right to buy)
3.89
2021-12-01
4
M
0
2037
0.00
D
2029-09-05
Common Stock
2037
46176
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
This transaction was executed in multiple trades at prices ranging from $15.26 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
/s/ Alicia Hager, as Attorney-in-Fact
2021-12-03